[Quelles indications pour la corticothérapie dans la BPCO ?]. - Université de Reims Champagne-Ardenne Access content directly
Journal Articles La Revue du Praticien Médecine Générale Year : 2024

[Quelles indications pour la corticothérapie dans la BPCO ?].

Abstract

WHAT ARE THE INDICATIONS FOR CORTICOSTEROID THERAPY IN COPD? In stable state chronic obstructive pulmonary disease (COPD), inhaled corticosteroids (ICS) should be used in case of frequent exacerbation only, associated with long-term bronchodilators including long-acting beta-agonist (LABA) and long-acting muscarinic antagonist (LAMA). When frequent exacerbations persist despite dual inhaled therapy (LABA + CSI or LABA+LAMA), triple inhaled therapy (LAMA+LABA+CSI) is indicated. In COPD exacerbation, the level of evidence for systemic corticosteroids is very low, justifying not to systematically prescribe systemic corticosteroids and when used to restrict this use to short-term (5 days) and low doses.
No file

Dates and versions

hal-04644564 , version 1 (11-07-2024)

Identifiers

  • HAL Id : hal-04644564 , version 1
  • PUBMED : 38833238

Cite

Gaëtan Deslée. [Quelles indications pour la corticothérapie dans la BPCO ?].. La Revue du Praticien Médecine Générale, 2024, 74 (5), pp.533-536. ⟨hal-04644564⟩

Collections

URCA P3CELL
8 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More